Warning: simplexml_load_string() [function.simplexml-load-string]: Entity: line 1: parser error : Start tag expected, '<' not found in /home/medicalh/public_html/medicalbooksfree.com/wp-content/plugins/amazon-product-in-a-post-plugin/inc/amazon-product-in-a-post-aws-signed-request.php on line 1239

Warning: simplexml_load_string() [function.simplexml-load-string]: Failed to connect to 54.239.31.126: Network is unreachable in /home/medicalh/public_html/medicalbooksfree.com/wp-content/plugins/amazon-product-in-a-post-plugin/inc/amazon-product-in-a-post-aws-signed-request.php on line 1239

Warning: simplexml_load_string() [function.simplexml-load-string]: ^ in /home/medicalh/public_html/medicalbooksfree.com/wp-content/plugins/amazon-product-in-a-post-plugin/inc/amazon-product-in-a-post-aws-signed-request.php on line 1239
Jun 202016
 

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)


Features: Used Book in Good Condition

Many practitioners in the pharmaceutical industry are still largely unfamiliar with benefit-risk assessment, despite its growing prominence in drug development and commercialization. Helping to alleviate this knowledge gap, Benefit-Risk Assessment in Pharmaceutical Research and Development provides a succinct overview of the key considerations relevant to benefit-risk assessment across the pharmaceutical R&D spectrum, from early clinical development to late-stage development to regulatory review to post-launch assessment.

The book first presents interpretations of benefit and risk in the context of a molecule moving from preclinical evaluation into its early testing in humans. It next considers benefit and risk characterization and assessment during a molecule’s journey from its clinical evaluation in humans through its submission to regulators for marketing approval. Throughout these sections, the book offers insight into the role of benefit-risk assessment in heightening understanding among key stakeholders by shaping questions and guiding discussions among scientists, physicians, developers, and regulatory agencies. The book also focuses on a molecule’s entry into the marketplace as a drug available for consumption by people. It explores the role of benefit-risk assessment as the relevance of carefully collected clinical efficacy and safety metrics fades in the wake of real-world use and evidence of effectiveness and safety.

Bringing together the expertise of 15 contributors from academia and the industry, this book offers an easy-to-read guide to the various facets of benefit-risk assessment in the major stages of pharmaceutical R&D. Suitable for those in both technical and managerial roles, it enables readers to communicate more effectively across their development chain as well as rationally and thoughtfully embed benefit-risk assessment into their R&D processes.

List Price: $89.95 USD
New From: $78.53 USD In Stock
Used from: $58.49 USD In Stock

GET IT FREE HERE

Share Button
Jun 202016
 

GET IT FREE HERE

Share Button
Jun 192016
 

GET IT FREE HERE

Share Button
Jun 152016
 

Computer-Aided Drug Discovery (Methods in Pharmacology and Toxicology)


This detailed volume examines computer-aided drug discovery (CADD), a crucial component of modern drug discovery programs that is widely utilized to identity and optimize bioactive compounds for the development of new drugs. With a focus on the methods that are commonly used in the early stage of drug discovery, chapters explore computer simulation, structure prediction, conformational sampling, binding site mapping, docking and scoring, in silico screening, and fragment-based drug design.  In addition to the state-of-the-art theoretical concept, this book also includes step-by-step, readily reproducible computational protocols as well as examples of various CADD strategies.  The limitations and potential pitfalls of different computational methods are discussed by experts, and tips and advice for their applications are suggested.

Practical and thorough, Computer-Aided Drug Discovery serves as an ideal addition to the Methods in Pharmacology and Toxicology series, guiding researchers toward their lab’s goals with this exciting and versatile technology.

List Price: $119.00 USD
New From: $76.85 USD In Stock
Used from: $89.69 USD In Stock

GET IT FREE HERE

Share Button
Jun 142016
 

GET IT FREE HERE

Share Button
Jun 132016
 

GET IT FREE HERE

Share Button
Jun 122016
 

GET IT FREE HERE

Share Button
Jun 122016
 

Heat Shock Protein Inhibitors: Success Stories (Topics in Medicinal Chemistry)


Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine. Therefore, the topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drugability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known guest editors.
List Price: $259.00 USD
New From: $175.23 USD In Stock
Used from: $195.30 USD In Stock

GET IT FREE HERE

Share Button
Jun 092016
 

GET IT FREE HERE

Share Button
Jun 092016
 

GET IT FREE HERE

Share Button